| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 235.302.160 $ | 100,04 | 6.227.154 | ||||||
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 11.695.516 $ | 4,97 | 72.199 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 11.631.774 $ | 4,95 | 343.019 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 11.613.170 $ | 4,94 | 61.927 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 9.698.375 $ | 4,12 | 44.490 | |
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 9.475.738 $ | 4,03 | 158.696 | |
| Liquidia Corp. | Liquidia Corp. | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 7.084.922 $ | 3,01 | 84.234 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 6.915.495 $ | 2,94 | 381.019 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 6.438.761 $ | 2,74 | 66.716 | |
| 10x Genomics, Inc. | 10x Genomics, Inc., Class A | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 5.340.754 $ | 2,27 | 112.984 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 5.286.673 $ | 2,25 | 280.758 | |
| Tango Therapeutics Inc. | Tango Therapeutics Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 5.074.669 $ | 2,16 | 186.706 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 5.071.570 $ | 2,16 | 90.742 | |
| Oscar Health, Inc. | Oscar Health, Inc., Class A | EC | 687793109 | Long | Börsenkurs (Stufe 1) | 4.934.571 $ | 2,10 | 158.058 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 4.894.301 $ | 2,08 | 23.863 | |
| agilon health, Inc. | agilon health, Inc. | EC | 00857U206 | Long | Börsenkurs (Stufe 1) | 4.857.803 $ | 2,07 | 53.027 | |
| Axogen, Inc. | Axogen, Inc. | EC | 05463X106 | Long | Börsenkurs (Stufe 1) | 4.841.149 $ | 2,06 | 114.692 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 4.738.538 $ | 2,01 | 55.978 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 4.732.328 $ | 2,01 | 48.127 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 4.536.538 $ | 1,93 | 405.048 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 4.532.516 $ | 1,93 | 17.925 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 4.459.881 $ | 1,90 | 81.355 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 4.440.220 $ | 1,89 | 57.568 | |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 4.282.164 $ | 1,82 | 243.859 | |
| Centene Corp. | Centene Corp. | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 4.203.894 $ | 1,79 | 67.565 | |
| Humana Inc. | Humana Inc. | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 4.160.375 $ | 1,77 | 11.434 | |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 4.096.582 $ | 1,74 | 14.247 | |
| Corcept Therapeutics Inc. | Corcept Therapeutics Inc. | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 4.032.910 $ | 1,71 | 35.225 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 3.994.772 $ | 1,70 | 72.884 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 3.740.733 $ | 1,59 | 40.860 | |
| Hims & Hers Health, Inc. | Hims & Hers Health, Inc. | EC | 433000106 | Long | Börsenkurs (Stufe 1) | 3.699.436 $ | 1,57 | 133.217 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 3.602.811 $ | 1,53 | 54.646 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 3.589.302 $ | 1,53 | 133.630 | |
| Establishment Labs Holdings Inc. | Establishment Labs Holdings Inc. | EC | G31249108 | Long | Börsenkurs (Stufe 1) | 3.554.461 $ | 1,51 | 38.410 | |
| uniQure N.V. | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 3.535.208 $ | 1,50 | 81.027 | |
| PACS Group, Inc. | PACS Group, Inc. | EC | 69380Q107 | Long | Börsenkurs (Stufe 1) | 3.131.073 $ | 1,33 | 68.052 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 3.092.232 $ | 1,31 | 58.311 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 2.749.892 $ | 1,17 | 150.679 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 2.747.722 $ | 1,17 | 8.055 | |
| National HealthCare Corp. | National HealthCare Corp. | EC | 635906100 | Long | Börsenkurs (Stufe 1) | 2.629.859 $ | 1,12 | 11.635 | |
| Amneal Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 2.626.190 $ | 1,12 | 143.351 | |
| Alkermes PLC | Alkermes PLC | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 2.580.891 $ | 1,10 | 52.682 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 2.556.169 $ | 1,09 | 55.185 | |
| NeoGenomics, Inc. | NeoGenomics, Inc. | EC | 64049M209 | Long | Börsenkurs (Stufe 1) | 2.531.657 $ | 1,08 | 165.576 | |
| Nuvation Bio Inc. | Nuvation Bio Inc. | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 2.499.521 $ | 1,06 | 394.869 | |
| TG Therapeutics, Inc. | TG Therapeutics, Inc. | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 2.482.195 $ | 1,06 | 47.707 | |
| AbSci Corp. | AbSci Corp. | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 2.337.882 $ | 0,99 | 300.499 | |
| Denali Therapeutics Inc. | Denali Therapeutics Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 2.286.139 $ | 0,97 | 99.311 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 2.094.554 $ | 0,89 | 27.202 | |
| AMN Healthcare Services, Inc. | AMN Healthcare Services, Inc. | EC | 001744101 | Long | Börsenkurs (Stufe 1) | 1.920.912 $ | 0,82 | 57.119 | |
| Guardian Pharmacy Services, Inc. | Guardian Pharmacy Services, Inc., Class A | EC | 40145W101 | Long | Börsenkurs (Stufe 1) | 1.872.022 $ | 0,80 | 47.357 | |
| Astrana Health, Inc. | Astrana Health, Inc. | EC | 03763A207 | Long | Börsenkurs (Stufe 1) | 1.709.796 $ | 0,73 | 48.082 | |
| Clover Health Investments, Corp. | Clover Health Investments, Corp. | EC | 18914F103 | Long | Börsenkurs (Stufe 1) | 1.703.941 $ | 0,72 | 408.619 | |
| Zevra Therapeutics, Inc. | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 1.513.469 $ | 0,64 | 159.145 | |
| NovoCure Ltd. | NovoCure Ltd. | EC | G6674U108 | Long | Börsenkurs (Stufe 1) | 1.448.132 $ | 0,62 | 97.583 | |
| Gesamt | 235.302.160 $ | 100,04 | 6.227.154 |